Skip to main content

Stay ahead of cervical cancer with comprehensive screening

For more than 50 years, we’ve been committed to providing diagnostic insights that can help you and your patients work together for better health. You can count on Quest for co-testing solutions that give you a more complete picture:

  • Age-based Smart Codes make it easy to order cervical cancer screening based on ACOG guidelines and STI screening as appropriate
  • Liquid-based Pap tests can detect abnormal cells on the cervix
  • Aptima® HPV mRNA testing detects the presence and activity of infection
  • Co-testing with Pap and HPV together offers superior detection of risk versus either test alone1

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.



  1. Kaufman HW, Alagia DP, Chen Z, et al. Contributions of liquid-    based (Papanicolaou) cytology and human papillomavirus testing in co-testing for detection of cervical cancer and precancer in the United States. Am J Clin Pathol. 2020;154(4):510-516. doi:10.1093/ajcp/aqaa074